Trending News

Trump Administration Issues AI Action Plan and AI Executive Orders

Winning the Race: America’s AI Action Plan

Innovation Over Regulation – Trump Unveils America’s AI Action Plan

Caught in the Act: Practical and Legal Considerations When Executives’ Office Love Affair Exposed

Florida’s CHOICE Act Becomes Law, Enhancing Certain Non-Compete Agreements

Labor Secretary Lifts Abeyance on OFCCP Disability and Veteran Matters

In Case You Missed It: DOL Prohibited From Collecting Liquidated Damages in Wage & Hour Pre-Litigation Investigations

SEC’s New Concept Release on Foreign Private Issuer Standards

What Regulated Businesses Should Know About the Supreme Court’s Recent NEPA Decision

NEW ATDS BATTLEGROUND: Texas Passes HUGE NEW AMENDMENT to Its State Telemarketing Law Reviving The Risk of Autodialer Cases

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Revive Therapeutics Announces Proposed Private Placement and Debt Settlement
Posted On Wednesday, July 30, 2025
Tarsus to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025
Posted On Wednesday, July 30, 2025
Apyx Medical Corporation to Participate in the Canaccord Genuity 45th Annual Growth Conference
Posted On Wednesday, July 30, 2025
Eledon Pharmaceuticals to Host a Conference Call to Discuss Updated Data from the Ongoing Phase 1b Trial of Tegoprubart in Kidney Transplantation Being Presented at the World Transplant Congress 2025
Posted On Wednesday, July 30, 2025
Aligos Therapeutics to Announce 2nd Quarter 2025 Financial Results on August 6, 2025
Posted On Wednesday, July 30, 2025
IMDX World Transplant Congress Late-Breaking Data Potentially Sets New Bar for Predicting Graft Rejection in Kidney Transplant Patients
Posted On Wednesday, July 30, 2025
Revolution Medicines to Report Financial Results for Second Quarter 2025 After Market Close on August 6, 2025
Posted On Wednesday, July 30, 2025
Codexis to Report Second Quarter 2025 Financial Results on August 13
Posted On Wednesday, July 30, 2025
Arvinas to Report Second Quarter 2025 Financial Results on August 6, 2025
Posted On Wednesday, July 30, 2025
Dyadic International, Inc. Announces Proposed Public Offering of Common Stock
Posted On Wednesday, July 30, 2025
Tevogen Highlights 74% Insider Ownership, Reinforcing Long-Term Vision
Posted On Wednesday, July 30, 2025
Two-Year Real-World Study of LEQEMBI® in the United States Presented at Alzheimer's Association International Conference (AAIC) 2025
Posted On Wednesday, July 30, 2025
FDA Provides Trethera Clearance to Initiate TRE-515 Clinical Trial in Healthy Volunteers to Study Food Effect and Biomarkers
Posted On Wednesday, July 30, 2025
Arbor Biotechnologies Announces First Patient Dosed at Mayo Clinic in the redePHine Phase 1/2 Study of ABO-101, an Investigational Gene Editing Treatment for Primary Hyperoxaluria Type 1
Posted On Wednesday, July 30, 2025
Moleculin Receives Notice of Intent to Grant New European Patent for Annamycin
Posted On Wednesday, July 30, 2025
NeuroStar Announces New Publication in JAACAP Open Highlighting Treatment Efficacy in Depressed Adolescents
Posted On Wednesday, July 30, 2025
Intelligent Bio Solutions Secures Major Drug Testing Tender with Leading London Transport Operator
Posted On Wednesday, July 30, 2025
Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates
Posted On Wednesday, July 30, 2025
Tenaya Receives Positive Safety Reviews from Independent DSMBs to Advance Both TN-201 and TN-401 Gene Therapy Clinical Trials as Designed
Posted On Wednesday, July 30, 2025
IMUNON Announces First Patient Dosed in Phase 3 OVATION 3 Study of IMNN-001 in Newly Diagnosed Advanced Ovarian Cancer
Posted On Wednesday, July 30, 2025
Candel Therapeutics to Present at the Canaccord Genuity 45th Annual Growth Conference
Posted On Wednesday, July 30, 2025
Kane Biotech Showcases revyve™ Preclinical and Clinical Case Study Findings at North American Wound Care Conferences
Posted On Wednesday, July 30, 2025
Nautilus Biotechnology Announces Agreement with the Allen Institute, Further Validating its Approach to Single-Molecule Proteomics
Posted On Wednesday, July 30, 2025
Spectral AI Schedules 2025 Second Quarter Financial Results and Conference Call
Posted On Wednesday, July 30, 2025
Corbus Pharmaceuticals Announces Upcoming Presentation of Dose Expansion Phase 1/2 Clinical Data for its Nectin-4 Targeting ADC CRB-701 at the 2025 ESMO Annual Congress
Posted On Wednesday, July 30, 2025

1
2
3
4
5
6
7
8
9
…
Next page
Last page

Print